Skip to main content
HNGE
NYSE Technology

10% Holder Insight Venture Partners Files to Sell $64.5M of Hinge Health

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$105
Mkt Cap
$8.473B
52W Low
$30.08
52W High
$107
52W Position info
249% above low
Off High info
1.9% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

HNGE has more than doubled off its 52-week low of $30.08.

Summary

A 10% stockholder filed to sell $64.5M of Hinge Health stock under a pre-arranged plan, later increased to $78.7M, adding to a heavy insider selling pattern near the 52-week high.

Updated with an SEC 144 filing · What changed

Updates

  1. · SEC 144 — Insight Venture Partners increased the proposed sale to 749,091 shares worth $78.7 million.


Key Events · Ownership and Investor Activity · HNGE

  • Updated · · SEC 144

    10% Holder Files $78.7M Form 144

    Insight Venture Partners (Cayman) X, L.P. filed to sell 614,262 shares worth approximately $64.5 million, later increased to 749,091 shares worth $78.7 million, the largest single Form 144 in the last 90 days.

  • New Seller Joins Distribution Pattern

    This filing introduces a new 10% stockholder seller to an ongoing insider distribution pattern that has seen $95.1M in net open-market sales over 90 days.

  • Pre-Arranged 10b5-1 Plan

    The sale is part of a 10b5-1 plan adopted on August 20, 2026, indicating the sale was scheduled in advance rather than a reaction to current price levels.

  • Trading Near 52-Week High

    The filing comes with the stock at $105, near its 52-week high of $107, adding supply overhang at elevated valuations.


Analysis · HNGE · Technology

A 10% stockholder, Insight Venture Partners (Cayman) X, L.P., has filed a Form 144 to sell 614,262 shares worth approximately $64.5 million, later increased to 749,091 shares worth $78.7 million. This is the largest single Form 144 filing in the last 90 days and introduces a new seller to an already heavy insider distribution pattern. The sale is part of a pre-arranged 10b5-1 plan adopted on August 20, 2026, which reduces the signal of opportunistic timing but still represents significant supply overhang near the 52-week high.

How filings like this one have moved

In the 30 days to Oct 14, 2026, 28.8% of the 1461 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HNGE was trading at $105.00 on NYSE in the Technology sector, with a market capitalization of approximately $8.5B. The 52-week trading range was $30.08 to $107.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HNGE - Latest Insights

HNGE
Oct 14, 2026, 5:55 PM EDT
Filing Type: 144
Importance Score:
7
HNGE
Sep 14, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
HNGE
Sep 11, 2026, 4:30 PM EDT
Filing Type: 144
Importance Score:
7
HNGE
Aug 04, 2026, 6:27 PM EDT
Source: Reuters
Importance Score:
8
HNGE
Aug 04, 2026, 4:20 PM EDT
Source: Reuters
Importance Score:
9